AstraZeneca LP v. Mylan Pharmaceuticals Inc
AstraZeneca LP v. Mylan Pharmaceuticals Inc is a federal patent lawsuit filed on 10/30/2015 in the District Court, D. Delaware. The case was terminated on 02/06/2018.
- Court
- District Court, D. Delaware (D. Del.)
Official Court Website → - Assigned judge
- Richard G. Andrews · 4,097 cases in index
- Docket number
- 1:15-cv-00999
- Cause
- 35:271 Patent Infringement
35 U.S.C. § 271 — Patent infringement - Nature of suit
- 830 Patent
Infringement of a patented invention. - Jurisdiction
- Federal Question
- Jury demand
- None
- Date filed
- 10/30/2015
- Date terminated
- 02/06/2018
11,768 Patent cases in this court are indexed here.
Parties
- plaintiff · Astrazeneca LP Pharmaceuticals & Biotechnology · 10349 cases
- defendant · Mylan Pharmaceuticals Inc · 388 cases
Part of a Larger Litigation Pattern
This is one of 389 Patent cases in our index naming MYLAN PHARMACEUTICALS INC — a possible mass-tort or coordinated-litigation cluster.
About Patent Lawsuits
Patent lawsuits allege infringement of a patented invention — that another party made, used, or sold a protected technology without authorization. These cases are common in technology and pharmaceutical industries.
Frequently Asked Questions
What is AstraZeneca LP v. Mylan Pharmaceuticals Inc?
AstraZeneca LP v. Mylan Pharmaceuticals Inc is a federal patent lawsuit filed on 10/30/2015 in the District Court, D. Delaware. The case was terminated on 02/06/2018. Patent lawsuits allege infringement of a patented invention — that another party made, used, or sold a protected technology without authorization. These cases are common in technology and pharmaceutical industries.
What type of case is this?
It is classified as “Patent” under the federal nature-of-suit system. Patent lawsuits allege infringement of a patented invention — that another party made, used, or sold a protected technology without authorization. These cases are common in technology and pharmaceutical industries.
What court is the case in?
The case is in the District Court, D. Delaware, docket number 1:15-cv-00999.
When was the case filed?
AstraZeneca LP v. Mylan Pharmaceuticals Inc was filed on 10/30/2015. It was terminated on 02/06/2018.
What law is the case brought under?
The docket lists the cause as 35 U.S.C. § 271 — Patent infringement.
Other Cases Involving These Parties
Related Patent Cases
Source: public U.S. federal court record (docket 13449931).